PET-CT surveillance versus neck dissection in advanced head and neck cancer

New England Journal of Medicine

Volumn 374, Issue 15, 2016, Pages 1444-1454

  Mehanna, Hisham ^a   Wong, Wai Lup ^b   Mcconkey, Christopher C ^c   Rahman, Joy K ^c   Robinson, Max ^b   Hartley, Andrew G J ^b   Nutting, Christopher ^d   Powell, Ned ^e   Al booz, Hoda ^f   Robinson, Martin ^d   Junor, Elizabeth ^g   Rizwanullah, Mohammed ^c   Von Zeidler, F Sandra V ^d   Wieshmann, Hulya ^h   Hulme, Claire ⁱ   Smith, Alison F ^j   Hall, Peter ^k   Dunn, Janet ^c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^c MOUNT VERNON HOSPITAL   (United Kingdom)

^d UNIVERSITY OF WARWICK   (United Kingdom)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

^f CARDIFF UNIVERSITY   (United Kingdom)

^g WESTON PARK HOSPITAL   (United Kingdom)

^h WESTERN GENERAL HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY OF LIVERPOOL   (United Kingdom)

^j UNIVERSITY OF LEEDS   (United Kingdom)

^k FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; CISPLATIN; DOCETAXEL; FLUOROURACIL; PLATINUM COMPLEX; PROTEIN P16;

ADULT; ADVANCED CANCER; AGED; CANCER RECURRENCE; CHEMORADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; FEMALE; FOLLOW UP; HAZARD RATIO; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NECK DISSECTION; OROPHARYNX CANCER; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; UNITED KINGDOM; WART VIRUS; CANCER STAGING; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIAL; HEAD AND NECK NEOPLASMS; INTENTION TO TREAT ANALYSIS; KAPLAN MEIER METHOD; LYMPHATIC METASTASIS; MIDDLE AGED; PROSPECTIVE STUDY; SURVIVAL RATE; TUMOR RECURRENCE;

CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; INTENTION TO TREAT ANALYSIS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; QUALITY OF LIFE; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84963856935     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1514493     Document Type: Conference Paper

References (26)

1. Thariat J, Ang KK, Allen PK, et al. Prediction of neck dissection requirement after definitive radiotherapy for head-andneck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2012; 82(3): e367-74.
2. National Head and Neck Cancer Audit 2012: eighth annual report. Leeds, United Kingdom: Health and Social Care Information Centre, 2012: 22 (http://www.hscic.gov.uk/catalogue/PUB11015/clin-audi-supp-prog-head-neck-dahn-11-12-rep0.pdf).
3. Stenson KM, Haraf DJ, Pelzer H, et al. The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: The feasibility of selective neck dissection. Arch Otolaryngol Head Neck Surg 2000; 126: 950-6.
4. Brizel DM, Prosnitz RG, Hunter S, et al. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004; 58: 1418-23.
5. Carinci F, Cassano L, Farina A, et al. Unresectable primary tumor of head and neck: does neck dissection combined with chemoradiotherapy improve survival? J Craniofac Surg 2001; 12: 438-43.
6. Hanna E, Alexiou M, Morgan J, et al. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations. Arch Otolaryngol Head Neck Surg 2004; 130: 861-7.
7. Liauw SL, Mancuso AA, Amdur RJ, et al. Postradiotherapy neck dissection for lymph node-positive head and neck cancer: The use of computed tomography to manage the neck. J Clin Oncol 2006; 24: 1421-7.
8. Lavertu P, Adelstein DJ, Saxton JP, et al. Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer. Head Neck 1997; 19: 559-66.
9. Isles MG, McConkey C, Mehanna HM. A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy. Clin Otolaryngol 2008; 33: 210-22.
10. Gupta T, Master Z, Kannan S, et al. Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: A systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 2011; 38: 2083-95.
11. Porceddu SV, Pryor DI, Burmeister E, et al. Results of a prospective study of positron emission tomography-directed management of residual nodal abnormalities in node-positive head and neck cancer after definitive radiotherapy with or without systemic therapy. Head Neck 2011; 33: 1675-82.
12. Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. TNM staging of the head and neck. 7th ed. New York: Springer, 2010.
13. Robbins KT, Clayman G, Levine PA, et al. Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. Arch Otolaryngol Head Neck Surg 2002; 128: 751-8.
14. Bjordal K, de Graeff A, Fayers PM, et al. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. Eur J Cancer 2000; 36: 1796-807.
15. Chen AY, Frankowski R, Bishop-Leone J, et al. The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: The M. D. Anderson dysphagia inventory. Arch Otolaryngol Head Neck Surg 2001; 127: 870-6.
16. Singhi AD, Westra WH. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer 2010; 116: 2166-73.
17. Early Breast Cancer Trialists' Collaborative Group. Treatment of early breast cancer. Volume 1: Worldwide Evidence 1985-1990. Oxford, United Kingdom: Oxford University Press, 1990.
18. Fayers PM. Interpreting quality of life data: population-based reference data for the EORTC QLQ-C30. Eur J Cancer 2001; 37: 1331-4.
19. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1141- 54.
20. Huang SH, O'Sullivan B, Xu W, et al. Temporal nodal regression and regional control after primary radiation therapy for N2-N3 head-and-neck cancer stratified by HPV status. Int J Radiat Oncol Biol Phys 2013; 87: 1078-85.
21. Mak D, Hicks RJ, Rischin D, et al. Treatment response in the neck: p16+ versus p16- oropharyngeal cancer. J Med Imaging Radiat Oncol 2013; 57: 364-72.
22. Moeller BJ, Rana V, Cannon BA, et al. Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer. J Clin Oncol 2009; 27: 2509-15.
23. Waldron J, Gilbert R, Eapen L, et al. Results of an Ontario Clinical Oncology Group (OCOG) prospective cohort study on the use of FDG PET/CT to predict the need for neck dissection following radiation therapy of head and neck cancer (HNC). Presented at the 2011 Annual Meeting of the American Society of Clinical Oncology, Chicago, June 3-7, 2011. abstract.
24. Pryor DI, Porceddu SV, Scuffham PA, Whitty JA, Thomas PA, Burmeister BH. Economic analysis of FDG-PET-guided management of the neck after primary chemoradiotherapy for node-positive head and neck squamous cell carcinoma. Head Neck 2013; 35: 1287-94.
25. Mehanna H, Beech T, Nicholson T, et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer - systematic review and meta-analysis of trends by time and region. Head Neck 2013; 35: 747-55.
26. Mehanna H, Franklin N, Compton N, et al. Geographic variation in human papillomavirus-related oropharyngeal cancer: data from four multinational randomized trials. Head Neck 2016 January 8 (Epub ahead of print).